One cluster demonstrated a positive response to both budesonide ( P = .02 ) and nedocromil ( P = .01 ) compared with placebo , whereas the other cluster demonstrated minimal responses to both budesonide ( P = .12 ) and nedocromil ( P = .56 ) compared with placebo .